Differential transcriptomic profiling in ibrutinib-naïve versus ibrutinib-resistant Richter syndrome

Hematol Oncol. 2022 Apr;40(2):302-306. doi: 10.1002/hon.2950. Epub 2021 Dec 3.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adenine / analogs & derivatives
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
  • Leukemia, Lymphocytic, Chronic, B-Cell* / genetics
  • Piperidines
  • Transcriptome*

Substances

  • Piperidines
  • ibrutinib
  • Adenine

Grants and funding